RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.35−0.01 (-2.91%)
Close on Nov 17, 2026Market cap $1.78MP/E –Yield –
RedHill Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$9.65M. The highest annual figure on record is -$9.37M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.65M | – |
| FY2024 | Dec 31, 2024 | -$9.37M | – |
| FY2023 | Dec 31, 2023 | -$35.82M | – |
| FY2022 | Dec 31, 2022 | -$29.19M | – |
| FY2021 | Dec 31, 2021 | -$65.05M | – |
| FY2020 | Dec 31, 2020 | -$48.58M | – |
| FY2019 | Dec 31, 2019 | -$40.75M | – |
| FY2018 | Dec 31, 2018 | -$34.46M | – |
| FY2017 | Dec 31, 2017 | -$44.77M | – |
| FY2016 | Dec 31, 2016 | -$28.26M | – |
| FY2015 | Dec 31, 2015 | -$17.83M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -$16.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.03M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.45M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.73M | – |
See a number that looks wrong?